0001415889-16-006297.txt : 20160621
0001415889-16-006297.hdr.sgml : 20160621
20160621213544
ACCESSION NUMBER: 0001415889-16-006297
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160619
FILED AS OF DATE: 20160621
DATE AS OF CHANGE: 20160621
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VistaGen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001411685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205093315
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-244-9990
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Excaliber Enterprises, Ltd.
DATE OF NAME CHANGE: 20070906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Singh Shawn
CENTRAL INDEX KEY: 0001412071
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37761
FILM NUMBER: 161725521
MAIL ADDRESS:
STREET 1: C/O VISTAGEN THERAPEUTICS, INC.
STREET 2: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4-06212016_060634.xml
X0306
4
2016-06-19
0001411685
VistaGen Therapeutics, Inc.
VTGN
0001412071
Singh Shawn
C/O VISTAGEN THERAPEUTICS, INC.
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
true
false
false
CHIEF EXECUTIVE OFFICER
Stock Option (Right to Buy)
3.49
2016-06-19
4
A
0
200000
0
A
2026-06-19
Common Stock
200000
200000
D
The Reporting Person's ability to exercise 75,000 of the options reported herein is conditioned upon stockholder approval of an amendment to the Issuer's 2008 Stock Incentive Plan.
25% of the shares subject to the option shall vest on the one year anniversary of the Grant Date and 1/48th of the shares subject to the option shall vest monthly every month thereafter until all awarded shares are fully vested.
/s/ Jerrold D. Dotson, Attorney-in-Fact
2016-06-21